Multidrug resistance associated proteins in multidrug resistance K Sodani, A Patel, RJ Kathawala, ZS Chen Chinese journal of cancer 31 (2), 58, 2012 | 318 | 2012 |
Nilotinib (AMN107, TasignaŽ) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters AK Tiwari, K Sodani, SR Wang, YH Kuang, CR Ashby Jr, X Chen, ... Biochemical pharmacology 78 (2), 153-161, 2009 | 249 | 2009 |
Revisiting the ABCs of multidrug resistance in cancer chemotherapy A K Tiwari, K Sodani, CL Dai, C R Ashby, ZS Chen Current pharmaceutical biotechnology 12 (4), 570-594, 2011 | 231 | 2011 |
Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models AK Tiwari, K Sodani, C Dai, AH Abuznait, S Singh, ZJ Xiao, A Patel, ... Cancer letters 328 (2), 307-317, 2013 | 124 | 2013 |
Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance YH Kuang, T Shen, X Chen, K Sodani, E Hopper-Borge, AK Tiwari, ... Biochemical pharmacology 79 (2), 154-161, 2010 | 118 | 2010 |
GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2-and ABCB1-mediated drug resistance K Sodani, AK Tiwari, S Singh, A Patel, ZJ Xiao, JJ Chen, YL Sun, ... Biochemical pharmacology 83 (12), 1613-1622, 2012 | 61 | 2012 |
Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo K Sodani, A Patel, N Anreddy, S Singh, DH Yang, RJ Kathawala, P Kumar, ... Biochemical pharmacology 89 (1), 52-61, 2014 | 58 | 2014 |
β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter HQ Guo, GN Zhang, YJ Wang, YK Zhang, K Sodani, TT Talele, CR Ashby, ... Oncology reports 31 (2), 858-866, 2014 | 58 | 2014 |
PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells A Patel, AK Tiwari, EE Chufan, K Sodani, N Anreddy, S Singh, ... Cancer chemotherapy and pharmacology 72, 189-199, 2013 | 58 | 2013 |
Saracatinib (AZD0530) is a potent modulator of ABCB1‐mediated multidrug resistance in vitro and in vivo KJ Liu, JH He, XD Su, HM Sim, JD Xie, XG Chen, F Wang, YJ Liang, ... International journal of cancer 132 (1), 224-235, 2013 | 56 | 2013 |
PDE 5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP‐binding Cassette C 10 … JJ Chen, YL Sun, AK Tiwari, ZJ Xiao, K Sodani, DH Yang, SG Vispute, ... Cancer science 103 (8), 1531-1537, 2012 | 55 | 2012 |
BBA, a Derivative of 23-Hydroxybetulinic Acid, Potently Reverses ABCB1-Mediated Drug Resistance in Vitro and in Vivo DM Zhang, C Shu, JJ Chen, K Sodani, J Wang, J Bhatnagar, P Lan, ... Molecular pharmaceutics 9 (11), 3147-3159, 2012 | 48 | 2012 |
Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar YL Sun, JJ Chen, P Kumar, K Chen, K Sodani, A Patel, YL Chen, ... PloS one 8 (2), e55576, 2013 | 45 | 2013 |
Masitinib antagonizes ATP-binding cassette subfamily C member 10–mediated Paclitaxel resistance: a preclinical study RJ Kathawala, K Sodani, K Chen, A Patel, AH Abuznait, N Anreddy, ... Molecular cancer therapeutics 13 (3), 714-723, 2014 | 44 | 2014 |
The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study RJ Kathawala, L Wei, N Anreddy, K Chen, A Patel, S Alqahtani, YK Zhang, ... Oncotarget 6 (1), 510, 2015 | 34 | 2015 |
PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR N Anreddy, A Patel, K Sodani, RJ Kathawala, EP Chen, JND Wurpel, ... Acta Pharmaceutica Sinica B 4 (3), 202-207, 2014 | 32 | 2014 |
Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells YL Sun, P Kumar, K Sodani, A Patel, Y Pan, MR Baer, ZS Chen, WQ Jiang Oncology reports 31 (4), 1605-1612, 2014 | 29 | 2014 |
OSI-930 analogues as novel reversal agents for ABCG2-mediated multidrug resistance YH Kuang, JP Patel, K Sodani, CP Wu, LQ Liao, A Patel, AK Tiwari, ... Biochemical pharmacology 84 (6), 766-774, 2012 | 27 | 2012 |
WHI‐P154 enhances the chemotherapeutic effect of anticancer agents in ABCG 2‐overexpressing cells H Zhang, YK Zhang, YJ Wang, RJ Kathawala, A Patel, H Zhu, K Sodani, ... Cancer science 105 (8), 1071-1078, 2014 | 23 | 2014 |
Design, synthesis and biological evaluation of N-arylphenyl-2, 2-dichloroacetamide analogues as anti-cancer agents T Li, Y Yang, C Cheng, AK Tiwari, K Sodani, Y Zhao, I Abraham, ZS Chen Bioorganic & medicinal chemistry letters 22 (23), 7268-7271, 2012 | 22 | 2012 |